Bewig B, Wang X D, Kirsten D, Dalhoff K, Schäfer H
Dept of Internal Medicine, Christian-Albrechts University, Kiel, Germany.
Eur Respir J. 2000 Feb;15(2):350-7. doi: 10.1034/j.1399-3003.2000.15b22.x.
Pulmonary alveolar proteinosis (PAP) is a rare disorder of unknown origin characterized by alveolar fillings with periodic acid-Schiff (PAS)-positive material mainly consisting of phospholipids. Mice defective in the granulocyte-macrophage colony-stimulating factor (GM-CSF) gene or the GM-CSF/interleukin (IL)-3/IL-5-receptor common beta chain (beta c) demonstrate a pathology resembling PAP. A recent study revealed defects in the beta c chain of the GM-CSF receptor in four out of eight paediatric patients. This study investigates the role of the GM-CSF coding region and components of the GM-CSF receptor in adult patients. Four adult patients with proven PAP were analysed for GM-CSF and GM-CSF-beta c receptor in regard to protein level, messenger ribonucleic acid (mRNA) expression and sequence composition. None of the adult patients displayed the mutation at position 1,835 of the beta c-receptor previously described in paediatric patients. Expression of the beta c receptor was found to be normal on the surface of peripheral blood cells. In three out of four patients GM-CSF release from blood cells failed to respond adequately to lipopolysaccharide (LPS). In one of these patients a heterozygous mutation was found in the GM-CSF complementary deoxyribonucleic acid (cDNA) from thymine (T) to cytosine (C) at position 382 of the published sequence putatively causing a change in the protein from isoleucine to threonine at position 117. This study indicates that the mutation of the beta chain receptors found in some of the paediatric patients suffering from pulmonary alveolar proteinosis is not a common problem in adult patients.
肺泡蛋白沉积症(PAP)是一种病因不明的罕见疾病,其特征是肺泡内充满主要由磷脂组成的过碘酸希夫(PAS)阳性物质。粒细胞-巨噬细胞集落刺激因子(GM-CSF)基因或GM-CSF/白细胞介素(IL)-3/IL-5受体共同β链(βc)有缺陷的小鼠表现出类似于PAP的病理特征。最近一项研究发现,8名儿科患者中有4名的GM-CSF受体βc链存在缺陷。本研究调查GM-CSF编码区和GM-CSF受体成分在成年患者中的作用。对4名确诊为PAP的成年患者的GM-CSF和GM-CSF-βc受体进行了蛋白质水平、信使核糖核酸(mRNA)表达及序列组成方面的分析。成年患者均未出现先前在儿科患者中描述的βc受体第1835位的突变。在外周血细胞表面发现βc受体表达正常。4名患者中有3名血细胞释放GM-CSF对脂多糖(LPS)的反应不充分。其中1例患者在已发表序列的第382位GM-CSF互补脱氧核糖核酸(cDNA)中发现了从胸腺嘧啶(T)到胞嘧啶(C)的杂合突变,推测这会导致蛋白质第117位的异亮氨酸变为苏氨酸。本研究表明,在一些患有肺泡蛋白沉积症的儿科患者中发现的β链受体突变在成年患者中并非常见问题。